Okupe Oluyemi 4
Accession 0001907056-26-000004
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:23 PM ET
Size
13.5 KB
Accession
0001907056-26-000004
Research Summary
AI-generated summary of this filing
Hims & Hers CFO Okupe Oluyemi Exercises Options, Sells 9,067 Shares
What Happened
Okupe Oluyemi, CFO of Hims & Hers (HIMS), exercised stock options on January 20, 2026 to acquire a total of 9,067 shares (7,317 at $5.01 and 1,750 at $11.53) for a cash cost of $56,836. On the same day he sold those 9,067 shares in an open‑market transaction for an aggregate reported proceeds of $275,114 (weighted average price $30.34). The filings include the option exercise records (coded M) and the open‑market sale (coded S).
Key Details
- Transaction date: January 20, 2026; Form 4 filed January 21, 2026 (timely).
- Options exercised: 7,317 shares at $5.01 ($36,658) and 1,750 shares at $11.53 ($20,178).
- Shares sold: 9,067 shares in the open market for total proceeds of $275,114; weighted average sale price $30.34 (range $30.21–$30.44).
- The $0.00 "disposed" entries reflect conversion of the derivative/options into shares as part of the exercise reporting.
- Plan note: Transactions were effected under a Rule 10b5‑1 trading plan adopted May 21, 2025 (footnote F1). Vesting schedules for the options are described in the filing (monthly vesting over four years; see F3/F4).
- Shares owned after the reported transactions: not disclosed in this Form 4.
Context
- This sequence (exercise of options followed by immediate sale of the acquired shares) is a common liquidity action and is often executed under pre‑arranged 10b5‑1 plans; it does not by itself indicate management sentiment about the company’s prospects.
- For clarity: M = option exercise/conversion, S = open‑market sale. The weighted average sale price and the plan disclosure mean the sale likely followed pre‑set instructions rather than ad‑hoc trading.
Insider Transaction Report
- Exercise/Conversion
Class A Common Stock
[F1]2026-01-20$5.01/sh+7,317$36,658→ 98,934 total - Exercise/Conversion
Class A Common Stock
[F1]2026-01-20$11.53/sh+1,750$20,178→ 100,684 total - Sale
Class A Common Stock
[F2]2026-01-20$30.34/sh−9,067$275,114→ 91,617 total - Exercise/Conversion
Stock Option (right to buy)
[F1][F3]2026-01-20−7,317→ 149,313 totalExercise: $5.01Exp: 2032-02-23→ Class A Common Stock (7,317 underlying) - Exercise/Conversion
Stock Option (right to buy)
[F1][F4]2026-01-20−1,750→ 42,996 totalExercise: $11.53Exp: 2033-03-01→ Class A Common Stock (1,750 underlying)
- 7,853(indirect: By Trust)
Class A Common Stock
Footnotes (4)
- [F1]The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
- [F2]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $30.21-$30.44. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]The Reporting Person received stock options to purchase shares of Class A Common Stock. The stock options vest over a 4-year period, with 1/48 of the shares vesting when the Reporting Person completes each month of continuous service, beginning March 24, 2022.
- [F4]The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.
Signature
Documents
Issuer
Hims & Hers Health, Inc.
CIK 0001773751
Related Parties
1- filerCIK 0001907056
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 4:23 PM ET
- Size
- 13.5 KB